The question remains: what will it take to prove that any protection device is having a meaningful impact on stroke risk?
A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the ...
In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
SILVER SPRING, MD — Unanimously disappointed with the end point used to determine clinical benefit, advisors to the US Food and Drug Administration (FDA) agreed the Sentinel Cerebral Protection System ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results